Theorem Clinical Research

CROs/Service Providers

Report: Strategic partnerships most effective biopharmaceutical outsourcing model

Monday, March 31, 2014 09:07 AM

Global CRO Parexel International has released Strategic Partnerships 2014: Driving Biopharmaceutical Outsourcing Effectiveness at the 23rd Annual Partnerships in Clinical Trials Conference in Las Vegas. It provides insights that highlight the value of these multi-year, highly integrated engagements between sponsors and CROs.

More... »


Fresenius launches rebranded Frenova Renal Research

Wednesday, March 26, 2014 11:37 AM

Fresenius Medical Care North America (FMCNA), a provider of dialysis services, has launched its newly branded Frenova Renal Research business, a phase I-IV drug and device clinical development partner dedicated exclusively to renal research.

More... »


AMRI to acquire Cedarburg Pharmaceuticals

Monday, March 24, 2014 02:42 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization based in Albany, N.Y., will acquire all outstanding shares of Cedarburg Pharmaceuticals for $38.2 million in cash. The transaction, including $2.8 million of assumed liabilities, is valued at $41 million.

More... »

TKL Research opens new primary research clinic

Monday, March 24, 2014 02:41 PM

TKL Research, a full-service CRO, has officially opened its new primary research clinic in Fair Lawn, N.J. This 25,000-square-foot facility offers a 70% increase in space over TKL’s former clinic, making it possible to create a sophisticated 30-bed phase I pharmacology unit and multiple examination rooms for outpatient studies.

More... »

Parexel enhances global clinical logistics services

Thursday, March 20, 2014 02:49 PM

Global CRO Parexel International has expanded its global clinical logistics services (CLS) capabilities. A new, state-of-the-art distribution center in Singapore and the recent expansion of the company’s facilities in Billerica, Mass., will help Parexel more effectively manage clients’ global clinical trial supply requirements.  

More... »

Onkodatamed joins Medis

Thursday, March 20, 2014 02:36 PM

Berlin-based clinical research alliance, Medis Research Group, has added Berlin-Brandenburg-based Onkodatamed to its portfolio. Medis Research Group, founded in November, previously consisting only of its two founding members, Allied Clinical Management and ICRC-Weyer, both Berlin-based CROs. The group was formed to better meet requirements of clinical trial sponsors for one-stop shop solutions, hence enabling the two CROs to combine clinical research experience and provide complete service solutions across all stages of the clinical development process.

More... »

Rescop opens in the U.K. and Australia

Wednesday, March 19, 2014 01:03 PM

Rescop(Regulatory System Compliance Partners), an international life sciences software and service provider, is opening offices in the U.K. and Australia. Following the opening of offices in Belgium and the U.S. in 2013, these new offices are part of the company’s internationalization strategy.

More... »

Mytrus launches innovation advisory board

Wednesday, March 19, 2014 12:43 PM

Mytrus, a provider of electronic informed consent and e-clinical technologies, has created a new Innovation Advisory Board comprised of industry experts to help shape the future of its clinical products and services.

More... »

CFS Clinical selects C3i for global technology support

Friday, March 14, 2014 12:22 PM

C3i, a provider of service desk support and business process outsourcing (BPO) services for the life sciences industry, has been selected by CFS Clinical to provide global 24x365 multilingual technology support services for their Site Activation and Investigator Payment Services.

More... »

PPD selected as member of new Medical Countermeasure Clinical Studies Network

Friday, March 14, 2014 11:18 AM

The Biomedical Advanced Research and Development Authority (BARDA) has chosen global CRO Pharmaceutical Product Development (PPD) as one of a select group to design and conduct clinical studies needed to develop medical countermeasures—drugs, vaccines and diagnostic tests—that help protect health against bioterrorism, pandemic influenza and other public health emergencies.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 2

Roche's $8.3B InterMune buy continues its buying spree with 'bolt-on' deal, fueling record M&A activity

FDA action plan seeks to close gap in women and minority patient representation in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs